Enhancer of zeste homolog 2 (EZH2) in pediatric soft tissue sarcomas: first implications
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1741-7015
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Enhancer of zeste homolog 2 (EZH2) in pediatric soft tissue sarcomas: first implications ; volume:9 ; number:1 ; day:25 ; month:5 ; year:2011 ; pages:1-9 ; date:12.2011
BMC medicine ; 9, Heft 1 (25.5.2011), 1-9, 12.2011
- Creator
-
Ciarapica, Roberta
- Contributor
- DOI
-
10.1186/1741-7015-9-63
- URN
-
urn:nbn:de:1111-2016072225454
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:47 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Ciarapica, Roberta
- Miele, Lucio
- Giordano, Antonio
- Locatelli, Franco
- Rota, Rossella
- SpringerLink (Online service)
Other Objects (12)
High EZH2 expression is correlated to metastatic disease in pediatric soft tissue sarcomas
Targeting epigenetics in sarcomas through EZH2 inhibition
Enhancer of zeste homolog 2 (EZH2) expression is an independent prognostic factor in renal cell carcinoma
Enhancer of zeste homolog 2 (EZH2) expression is an independent prognostic factor in renal cell carcinoma
Functional analysis and targeted inhibition of the enhancer of zeste homolog 2 (EZH2)-protein in human cancer cells
Pediatric bone and soft tissue sarcomas
Pediatric bone and soft-tissue sarcomas
Analysis of the correlation between Zeste enhancer homolog 2 (EZH2) mRNA expression and the prognosis of mesothelioma patients and immune infiltration
Emerging trends in immunotherapy for pediatric sarcomas
Notch signaling in pediatric soft tissue sarcomas
Targeting enhancer of zeste homolog 2 protects against acute kidney injury
Overexpression of Enhancer of zeste homolog 2 (EZH2) characterizes an aggressive subset of prostate cancers and predicts patient prognosis independently from pre- and postoperatively assessed clinicopathological parameters
High EZH2 expression is correlated to metastatic disease in pediatric soft tissue sarcomas
Targeting epigenetics in sarcomas through EZH2 inhibition
Enhancer of zeste homolog 2 (EZH2) expression is an independent prognostic factor in renal cell carcinoma
Enhancer of zeste homolog 2 (EZH2) expression is an independent prognostic factor in renal cell carcinoma
Functional analysis and targeted inhibition of the enhancer of zeste homolog 2 (EZH2)-protein in human cancer cells
Pediatric bone and soft tissue sarcomas
Pediatric bone and soft-tissue sarcomas
Analysis of the correlation between Zeste enhancer homolog 2 (EZH2) mRNA expression and the prognosis of mesothelioma patients and immune infiltration
Emerging trends in immunotherapy for pediatric sarcomas
Notch signaling in pediatric soft tissue sarcomas
Targeting enhancer of zeste homolog 2 protects against acute kidney injury
Overexpression of Enhancer of zeste homolog 2 (EZH2) characterizes an aggressive subset of prostate cancers and predicts patient prognosis independently from pre- and postoperatively assessed clinicopathological parameters
High EZH2 expression is correlated to metastatic disease in pediatric soft tissue sarcomas
Targeting epigenetics in sarcomas through EZH2 inhibition
Enhancer of zeste homolog 2 (EZH2) expression is an independent prognostic factor in renal cell carcinoma
Enhancer of zeste homolog 2 (EZH2) expression is an independent prognostic factor in renal cell carcinoma
Functional analysis and targeted inhibition of the enhancer of zeste homolog 2 (EZH2)-protein in human cancer cells
Pediatric bone and soft tissue sarcomas
Pediatric bone and soft-tissue sarcomas
Analysis of the correlation between Zeste enhancer homolog 2 (EZH2) mRNA expression and the prognosis of mesothelioma patients and immune infiltration
Emerging trends in immunotherapy for pediatric sarcomas
Notch signaling in pediatric soft tissue sarcomas
Targeting enhancer of zeste homolog 2 protects against acute kidney injury